
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Nanomedicine therapeutic approaches to overcome cancer drug resistance
Janet L. Markman, Arthur Rekechenetskiy, Eggehard Holler, et al.
Advanced Drug Delivery Reviews (2013) Vol. 65, Iss. 13-14, pp. 1866-1879
Open Access | Times Cited: 670
Janet L. Markman, Arthur Rekechenetskiy, Eggehard Holler, et al.
Advanced Drug Delivery Reviews (2013) Vol. 65, Iss. 13-14, pp. 1866-1879
Open Access | Times Cited: 670
Showing 1-25 of 670 citing articles:
Development of exosome-encapsulated paclitaxel to overcome MDR in cancer cells
Myoung Soo Kim, Matthew J. Haney, Yuling Zhao, et al.
Nanomedicine Nanotechnology Biology and Medicine (2015) Vol. 12, Iss. 3, pp. 655-664
Open Access | Times Cited: 1248
Myoung Soo Kim, Matthew J. Haney, Yuling Zhao, et al.
Nanomedicine Nanotechnology Biology and Medicine (2015) Vol. 12, Iss. 3, pp. 655-664
Open Access | Times Cited: 1248
Mechanisms and biomaterials in pH-responsive tumour targeted drug delivery: A review
Manju Kanamala, William R. Wilson, Mimi Yang, et al.
Biomaterials (2016) Vol. 85, pp. 152-167
Closed Access | Times Cited: 862
Manju Kanamala, William R. Wilson, Mimi Yang, et al.
Biomaterials (2016) Vol. 85, pp. 152-167
Closed Access | Times Cited: 862
Nanomaterials for cancer therapy: current progress and perspectives
Zhe Cheng, Maoyu Li, Raja Dey, et al.
Journal of Hematology & Oncology (2021) Vol. 14, Iss. 1
Open Access | Times Cited: 860
Zhe Cheng, Maoyu Li, Raja Dey, et al.
Journal of Hematology & Oncology (2021) Vol. 14, Iss. 1
Open Access | Times Cited: 860
Targeted therapy in chronic diseases using nanomaterial-based drug delivery vehicles
Akhand Pratap Singh, Arpan Biswas, Aparna Wagle Shukla, et al.
Signal Transduction and Targeted Therapy (2019) Vol. 4, Iss. 1
Open Access | Times Cited: 512
Akhand Pratap Singh, Arpan Biswas, Aparna Wagle Shukla, et al.
Signal Transduction and Targeted Therapy (2019) Vol. 4, Iss. 1
Open Access | Times Cited: 512
Emerging roles of lncRNA in cancer and therapeutic opportunities.
Mingchun Jiang, Jiaojiao Ni, Wenyu Cui, et al.
PubMed (2019) Vol. 9, Iss. 7, pp. 1354-1366
Closed Access | Times Cited: 443
Mingchun Jiang, Jiaojiao Ni, Wenyu Cui, et al.
PubMed (2019) Vol. 9, Iss. 7, pp. 1354-1366
Closed Access | Times Cited: 443
Multidrug Resistance in Cancer: Understanding Molecular Mechanisms, Immunoprevention and Therapeutic Approaches
Talha Bin Emran, Asif Shahriar, Aar Rafi Mahmud, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 349
Talha Bin Emran, Asif Shahriar, Aar Rafi Mahmud, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 349
Synthetic polypeptides: from polymer design to supramolecular assembly and biomedical application
Ziyuan Song, Zhiyuan Han, Shixian Lv, et al.
Chemical Society Reviews (2017) Vol. 46, Iss. 21, pp. 6570-6599
Closed Access | Times Cited: 343
Ziyuan Song, Zhiyuan Han, Shixian Lv, et al.
Chemical Society Reviews (2017) Vol. 46, Iss. 21, pp. 6570-6599
Closed Access | Times Cited: 343
Recent progress in nanomedicine for enhanced cancer chemotherapy
Guoqing Wei, Yu Wang, Guang Yang, et al.
Theranostics (2021) Vol. 11, Iss. 13, pp. 6370-6392
Open Access | Times Cited: 340
Guoqing Wei, Yu Wang, Guang Yang, et al.
Theranostics (2021) Vol. 11, Iss. 13, pp. 6370-6392
Open Access | Times Cited: 340
Advances in redox-responsive drug delivery systems of tumor microenvironment
Xiaoshuang Guo, Yuan Cheng, Xiaotian Zhao, et al.
Journal of Nanobiotechnology (2018) Vol. 16, Iss. 1
Open Access | Times Cited: 338
Xiaoshuang Guo, Yuan Cheng, Xiaotian Zhao, et al.
Journal of Nanobiotechnology (2018) Vol. 16, Iss. 1
Open Access | Times Cited: 338
Natural products as multidrug resistance modulators in cancer
Amit Kumar, Vikas Jaitak
European Journal of Medicinal Chemistry (2019) Vol. 176, pp. 268-291
Closed Access | Times Cited: 282
Amit Kumar, Vikas Jaitak
European Journal of Medicinal Chemistry (2019) Vol. 176, pp. 268-291
Closed Access | Times Cited: 282
Bottom-Up Synthesis of Metal-Ion-Doped WS2 Nanoflakes for Cancer Theranostics
Liang Cheng, Chao Yuan, Sida Shen, et al.
ACS Nano (2015) Vol. 9, Iss. 11, pp. 11090-11101
Closed Access | Times Cited: 277
Liang Cheng, Chao Yuan, Sida Shen, et al.
ACS Nano (2015) Vol. 9, Iss. 11, pp. 11090-11101
Closed Access | Times Cited: 277
Reversibly crosslinked hyaluronic acid nanoparticles for active targeting and intelligent delivery of doxorubicin to drug resistant CD44+ human breast tumor xenografts
Yinan Zhong, Jian Zhang, Ru Cheng, et al.
Journal of Controlled Release (2015) Vol. 205, pp. 144-154
Closed Access | Times Cited: 272
Yinan Zhong, Jian Zhang, Ru Cheng, et al.
Journal of Controlled Release (2015) Vol. 205, pp. 144-154
Closed Access | Times Cited: 272
Nanotechnology-based antiviral therapeutics
Malobika Chakravarty, Amisha Vora
Drug Delivery and Translational Research (2020) Vol. 11, Iss. 3, pp. 748-787
Open Access | Times Cited: 264
Malobika Chakravarty, Amisha Vora
Drug Delivery and Translational Research (2020) Vol. 11, Iss. 3, pp. 748-787
Open Access | Times Cited: 264
Self-Assembled Core–Shell Nanoparticles for Combined Chemotherapy and Photodynamic Therapy of Resistant Head and Neck Cancers
Chunbai He, Demin Liu, Wenbin Lin
ACS Nano (2015) Vol. 9, Iss. 1, pp. 991-1003
Closed Access | Times Cited: 261
Chunbai He, Demin Liu, Wenbin Lin
ACS Nano (2015) Vol. 9, Iss. 1, pp. 991-1003
Closed Access | Times Cited: 261
The PDGF/PDGFR pathway as a drug target
Natalia Papadopoulos, Johan Lennartsson
Molecular Aspects of Medicine (2017) Vol. 62, pp. 75-88
Closed Access | Times Cited: 251
Natalia Papadopoulos, Johan Lennartsson
Molecular Aspects of Medicine (2017) Vol. 62, pp. 75-88
Closed Access | Times Cited: 251
Magnetic Nanoparticles for Precision Oncology: Theranostic Magnetic Iron Oxide Nanoparticles for Image-Guided and Targeted Cancer Therapy
Lei Zhu, Zhiyang Zhou, Hui Mao, et al.
Nanomedicine (2016) Vol. 12, Iss. 1, pp. 73-87
Open Access | Times Cited: 248
Lei Zhu, Zhiyang Zhou, Hui Mao, et al.
Nanomedicine (2016) Vol. 12, Iss. 1, pp. 73-87
Open Access | Times Cited: 248
Synergistic nanomedicine by combined gene and photothermal therapy
Jinhwan Kim, Jihoon Kim, Cherlhyun Jeong, et al.
Advanced Drug Delivery Reviews (2015) Vol. 98, pp. 99-112
Closed Access | Times Cited: 247
Jinhwan Kim, Jihoon Kim, Cherlhyun Jeong, et al.
Advanced Drug Delivery Reviews (2015) Vol. 98, pp. 99-112
Closed Access | Times Cited: 247
Mesoporous silica nanoparticles with organo-bridged silsesquioxane framework as innovative platforms for bioimaging and therapeutic agent delivery
Xin Du, Xiaoyu Li, Lin Xiong, et al.
Biomaterials (2016) Vol. 91, pp. 90-127
Closed Access | Times Cited: 246
Xin Du, Xiaoyu Li, Lin Xiong, et al.
Biomaterials (2016) Vol. 91, pp. 90-127
Closed Access | Times Cited: 246
Review of Natural Compounds for Potential Skin Cancer Treatment
Tawona N. Chinembiri, Du Plessis, Minja Gerber, et al.
Molecules (2014) Vol. 19, Iss. 8, pp. 11679-11721
Open Access | Times Cited: 245
Tawona N. Chinembiri, Du Plessis, Minja Gerber, et al.
Molecules (2014) Vol. 19, Iss. 8, pp. 11679-11721
Open Access | Times Cited: 245
The role of tumor microenvironment in therapeutic resistance
Beomseok Son, Sungmin Lee, HyeSook Youn, et al.
Oncotarget (2016) Vol. 8, Iss. 3, pp. 3933-3945
Open Access | Times Cited: 244
Beomseok Son, Sungmin Lee, HyeSook Youn, et al.
Oncotarget (2016) Vol. 8, Iss. 3, pp. 3933-3945
Open Access | Times Cited: 244
Pulmonary delivery of nanoparticle chemotherapy for the treatment of lung cancers: challenges and opportunities
Sharad Mangal, Wei Gao, Tonglei Li, et al.
Acta Pharmacologica Sinica (2017) Vol. 38, Iss. 6, pp. 782-797
Open Access | Times Cited: 244
Sharad Mangal, Wei Gao, Tonglei Li, et al.
Acta Pharmacologica Sinica (2017) Vol. 38, Iss. 6, pp. 782-797
Open Access | Times Cited: 244
Chitosan nanopolymers: An overview of drug delivery against cancer
Rajasree Shanmuganathan, Thomas Nesakumar Jebakumar Immanuel Edison, Felix LewisOscar, et al.
International Journal of Biological Macromolecules (2019) Vol. 130, pp. 727-736
Closed Access | Times Cited: 230
Rajasree Shanmuganathan, Thomas Nesakumar Jebakumar Immanuel Edison, Felix LewisOscar, et al.
International Journal of Biological Macromolecules (2019) Vol. 130, pp. 727-736
Closed Access | Times Cited: 230
Advanced drug delivery applications of layered double hydroxide
V.K. Ameena Shirin, Renu Sankar, Asha P. Johnson, et al.
Journal of Controlled Release (2020) Vol. 330, pp. 398-426
Closed Access | Times Cited: 217
V.K. Ameena Shirin, Renu Sankar, Asha P. Johnson, et al.
Journal of Controlled Release (2020) Vol. 330, pp. 398-426
Closed Access | Times Cited: 217
Stimuli-Responsive Nanomedicines for Overcoming Cancer Multidrug Resistance
Lei Zhou, Hao Wang, Yaping Li
Theranostics (2018) Vol. 8, Iss. 4, pp. 1059-1074
Open Access | Times Cited: 211
Lei Zhou, Hao Wang, Yaping Li
Theranostics (2018) Vol. 8, Iss. 4, pp. 1059-1074
Open Access | Times Cited: 211
Nanostructured materials functionalized with metal complexes: In search of alternatives for administering anticancer metallodrugs
Waseem A. Wani, Sanjiv Prashar, Sheikh Shreaz, et al.
Coordination Chemistry Reviews (2016) Vol. 312, pp. 67-98
Closed Access | Times Cited: 204
Waseem A. Wani, Sanjiv Prashar, Sheikh Shreaz, et al.
Coordination Chemistry Reviews (2016) Vol. 312, pp. 67-98
Closed Access | Times Cited: 204